Phosphatidylinositol 3-kinase (PI3K)
phosphatidylinositol 3-kinase (PI3K) is a key regulatory enzyme involved in cellular signaling processes and a critical target in drug development for multiple disease indications.
phosphatidylinositol 3-kinase (Phosphatidylinositol 3-kinase (PI3K)) is a key regulatory enzyme involved in cellular signaling processes and a critical target in drug development for multiple disease indications. PI3K catalyzes the phosphorylation of phosphatidylinositol lipids in cell membranes, generating secondary messengers that activate downstream signaling cascades. The enzyme exists in multiple isoforms (notably PI3K-δ and PI3K-γ), each with distinct tissue distribution and functional roles in immune cells, vascular endothelial cells, and other cell types. As a central node in the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Protein kinase B (PKB)) signaling pathway, PI3K regulates fundamental cellular processes including proliferation, survival, differentiation, and metabolism. Due to its dysregulation in various cancers and inflammatory diseases, PI3K has emerged as a major pharmaceutical target, with multiple small-molecule inhibitors and combination therapeutic strategies currently under investigation.
Where the papers sit
26 papers from the last 6 months study Phosphatidylinositol 3-kinase (PI3K) directly · updated from PubMed 16 Nov 2026
Study type 0 clinical trials · 2 human data · 20 preclinical · 4 unclassified
Themes one subject · 1 paradigm shift
Those 26 are all about one subject.
-
PI3K-Linked Disease Biology
PI3K signaling is being treated as a cross-disease therapeutic axis spanning cancer, fibrosis, wound healing, metabolic disorders and neurodegeneration. Studies pair PI3K inhibition with HDAC8 blockade, kinase combinations or tumor-microenvironment delivery, while other work uses natural compounds to modulate PI3K/AKT, mTOR or NF-κB pathways. Omics and expression analyses increasingly seek prognostic markers and mechanisms of resistance or tissue repair. The evidence remains exploratory, with no single intervention or disease setting dominating.
PI3K activation, rather than inhibition, can be therapeutic in tissue-injury models
The hierarchically aligned halloysite-nanotube foam study in diabetic rats found that foam-induced macrophage repair responses required activation of PI3K/AKT, because PI3K inhibition weakened its anti-inflammatory effect 42606047Aug. The ergothioneine study in photochemical and middle cerebral artery occlusion models of ischemic stroke likewise associated protection from infarction, impaired perfusion, and glial injury with activation of the PI3K/Akt/Nrf2 pathway 42214028May. Together, these independent wound-healing and cerebral-ischemia models reverse the inhibitory intervention logic used for PI3K-targeted cancer treatment: in tissue injury, enhancing rather than suppressing PI3K signaling can drive the beneficial outcome.
Papers
The 26 papers from the last 6 months that study Phosphatidylinositol 3-kinase (PI3K) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
PI3K-Linked Disease Biology (26)
- Design, Synthesis, and Biological Evaluation of Novel Benzimidazole Derivatives as Dual PI3K/HDAC8 Inhibitors with Potent Anti-Cervical Cancer Activity InVivo. Journal of medicinal chemistry · 12 Nov 2026 PMID 43018604
- Deciphering molecular mechanisms of synergistic growth reduction in kinase inhibitor combinations. Molecular & cellular proteomics : MCP · 2 Nov 2026 PMID 42971429
- Exploration of the therapeutic mechanisms of nuciferine in polyendocrine metabolic ovarian syndrome treatment based on multi-omics approaches. Genomics · 27 Oct 2026 PMID 42946178
- Comment on "Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival". Breast cancer research and treatment · 20 Oct 2026 PMID 42901996
- Proteomic regulation of anti-proliferative and anti-migratory activity by potent phytochemicals from Pistacia integerrima J.L. Steward Ex Brandis via PI3K, AKT1, and KRAS for Lung Cancer. Molecular biology reports · 12 Sept 2026 PMID 42730982
- Engineered matrices reveal sulfation-mediated stress adaptation and drug-specific modulation of chemotherapeutic response. Biomaterials science · 1 Sept 2026 PMID 42677696
- Ginkgolide A alleviated liver fibrosis by modulating PI3K/AKT/NF-κB signaling to inhibit M1 macrophage polarization and macrophage-HSC crosstalk. International immunopharmacology · 27 Aug 2026 PMID 42659933
- Design, synthesis and biological evaluation of novel 1,3,5-triazine derivatives containing benzo[d]imidazole scaffold as PI3K inhibitors. Bioorganic chemistry · 18 Aug 2026 PMID 42612260
- Hierarchically Aligned HNTs-Based Composite Foam with Immunomodulatory Activity for Diabetic Wound Healing. ACS applied bio materials · 17 Aug 2026 PMID 42606047
- pH-Responsive liposomes co-delivering a membrane-active peptide and the PI3Kγ inhibitor to reconstruct the tumor microenvironment for enhanced antitumor immunotherapy. Biomaterials science · 17 Aug 2026 PMID 42605855
- UBC9 and PI3K Expression in Colorectal Cancer: Possible Prognostic Role. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 29 Jul 2026 PMID 42522541
- Targeting casein kinase 1α-mediated FADD phosphorylation restores sensitivity in select CDK4/6 inhibitor-resistant breast cancer models. The Journal of clinical investigation · 28 Jul 2026 PMID 42518285
- Extraction-driven structural modulation dictates the anti-diabetic potency of Notopterygium franchetii polysaccharides. Carbohydrate polymers · 23 Jul 2026 PMID 42493156
- ADSC-Exo-bFGF promotes skin wound healing and correlates with the PI3K/AKT signaling pathway activation. Journal of molecular histology · 16 Jul 2026 PMID 42461467
- Multi-omics analysis of arginine metabolism in ovarian cancer: A prognostic signature and GTF2F2-driven stromal remodeling. Translational oncology · 13 Jul 2026 PMID 42442222
- Chronic Lithium Exposure Reshapes PI3K-mTOR-linked Proteostatic Networks in the Hippocampus of an Alzheimer's Disease Mouse Model. Molecular neurobiology · 6 Jul 2026 PMID 42410183
- Asymmetric hydrogel with "spear-shield" properties promotes diabetic foot ulcer healing by modulating macrophage autophagy. Journal of controlled release : official journal of the Controlled Release Society · 6 Jul 2026 PMID 42409241
- Benefits and challenges of adding BKM120 to a BI-3406 plus trametinib combination therapy. BMC cancer · 3 Jul 2026 PMID 42399819
- Xiaokeping combined with low-carbohydrate diet slows cognitive decline in diabetic rats through activating TGF-β1/Smad7 signaling. Biotechnic & histochemistry : official publication of the Biological Stain Commission · 22 Jun 2026 PMID 42324965
- Designing inhalable amorphous solid dispersions to mitigate crystallization risks in atropisomer development. International journal of pharmaceutics · 19 Jun 2026 PMID 42320735
- Vitamin D regulates lipid metabolism in granulosa cells via the FABP3-associated PI3K/Akt pathway in polycystic ovary syndrome. International immunopharmacology · 16 Jun 2026 PMID 42302377
- From virtual screening to reality: Identifying potent PI3Kγ inhibitors for inflammation treatment by harnessing machine learning and biological validation. European journal of medicinal chemistry · 13 Jun 2026 PMID 42288026
- Dimethyl fumarate attenuates post-infarct myocardial injury and is associated with modulation of the NRG-1/ErbB2/Akt pathway and reduction of oxidative stress. European journal of pharmacology · 2 Jun 2026 PMID 42229738
- Ergothioneine exerts neuroprotection in experimental ischemic stroke via activation of PI3K/Akt/Nrf2 pathway. Neuroreport · 29 May 2026 PMID 42214028
- Nuciferine alleviates cerebral ischemia-reperfusion injury by inhibiting mPTP opening via activating the phosphatidylinositol 3-kinase/protein kinase B/glycogen synthase kinase 3 beta pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology · 22 May 2026 PMID 42172986
- Design, synthesis, and biological evaluation of 2-morpholino-4H-chromen-4-one derivatives as a potent dual PI3K/BRD4 inhibitors. European journal of medicinal chemistry · 21 May 2026 PMID 42166816
By study type
Human data, design not indexed (2)
- Comment on "Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival". Breast cancer research and treatment · 20 Oct 2026 PMID 42901996
- UBC9 and PI3K Expression in Colorectal Cancer: Possible Prognostic Role. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 29 Jul 2026 PMID 42522541
Preclinical: animal, cell and lab studies (20)
- Design, Synthesis, and Biological Evaluation of Novel Benzimidazole Derivatives as Dual PI3K/HDAC8 Inhibitors with Potent Anti-Cervical Cancer Activity InVivo. Journal of medicinal chemistry · 12 Nov 2026 PMID 43018604
- Proteomic regulation of anti-proliferative and anti-migratory activity by potent phytochemicals from Pistacia integerrima J.L. Steward Ex Brandis via PI3K, AKT1, and KRAS for Lung Cancer. Molecular biology reports · 12 Sept 2026 PMID 42730982
- Engineered matrices reveal sulfation-mediated stress adaptation and drug-specific modulation of chemotherapeutic response. Biomaterials science · 1 Sept 2026 PMID 42677696
- Design, synthesis and biological evaluation of novel 1,3,5-triazine derivatives containing benzo[d]imidazole scaffold as PI3K inhibitors. Bioorganic chemistry · 18 Aug 2026 PMID 42612260
- Hierarchically Aligned HNTs-Based Composite Foam with Immunomodulatory Activity for Diabetic Wound Healing. ACS applied bio materials · 17 Aug 2026 PMID 42606047
- pH-Responsive liposomes co-delivering a membrane-active peptide and the PI3Kγ inhibitor to reconstruct the tumor microenvironment for enhanced antitumor immunotherapy. Biomaterials science · 17 Aug 2026 PMID 42605855
- Targeting casein kinase 1α-mediated FADD phosphorylation restores sensitivity in select CDK4/6 inhibitor-resistant breast cancer models. The Journal of clinical investigation · 28 Jul 2026 PMID 42518285
- Extraction-driven structural modulation dictates the anti-diabetic potency of Notopterygium franchetii polysaccharides. Carbohydrate polymers · 23 Jul 2026 PMID 42493156
- ADSC-Exo-bFGF promotes skin wound healing and correlates with the PI3K/AKT signaling pathway activation. Journal of molecular histology · 16 Jul 2026 PMID 42461467
- Chronic Lithium Exposure Reshapes PI3K-mTOR-linked Proteostatic Networks in the Hippocampus of an Alzheimer's Disease Mouse Model. Molecular neurobiology · 6 Jul 2026 PMID 42410183
- Asymmetric hydrogel with "spear-shield" properties promotes diabetic foot ulcer healing by modulating macrophage autophagy. Journal of controlled release : official journal of the Controlled Release Society · 6 Jul 2026 PMID 42409241
- Benefits and challenges of adding BKM120 to a BI-3406 plus trametinib combination therapy. BMC cancer · 3 Jul 2026 PMID 42399819
- Xiaokeping combined with low-carbohydrate diet slows cognitive decline in diabetic rats through activating TGF-β1/Smad7 signaling. Biotechnic & histochemistry : official publication of the Biological Stain Commission · 22 Jun 2026 PMID 42324965
- Designing inhalable amorphous solid dispersions to mitigate crystallization risks in atropisomer development. International journal of pharmaceutics · 19 Jun 2026 PMID 42320735
- Vitamin D regulates lipid metabolism in granulosa cells via the FABP3-associated PI3K/Akt pathway in polycystic ovary syndrome. International immunopharmacology · 16 Jun 2026 PMID 42302377
- From virtual screening to reality: Identifying potent PI3Kγ inhibitors for inflammation treatment by harnessing machine learning and biological validation. European journal of medicinal chemistry · 13 Jun 2026 PMID 42288026
- Dimethyl fumarate attenuates post-infarct myocardial injury and is associated with modulation of the NRG-1/ErbB2/Akt pathway and reduction of oxidative stress. European journal of pharmacology · 2 Jun 2026 PMID 42229738
- Ergothioneine exerts neuroprotection in experimental ischemic stroke via activation of PI3K/Akt/Nrf2 pathway. Neuroreport · 29 May 2026 PMID 42214028
- Nuciferine alleviates cerebral ischemia-reperfusion injury by inhibiting mPTP opening via activating the phosphatidylinositol 3-kinase/protein kinase B/glycogen synthase kinase 3 beta pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology · 22 May 2026 PMID 42172986
- Design, synthesis, and biological evaluation of 2-morpholino-4H-chromen-4-one derivatives as a potent dual PI3K/BRD4 inhibitors. European journal of medicinal chemistry · 21 May 2026 PMID 42166816
Unclassified: not yet indexed with MeSH (4)
- Deciphering molecular mechanisms of synergistic growth reduction in kinase inhibitor combinations. Molecular & cellular proteomics : MCP · 2 Nov 2026 PMID 42971429
- Exploration of the therapeutic mechanisms of nuciferine in polyendocrine metabolic ovarian syndrome treatment based on multi-omics approaches. Genomics · 27 Oct 2026 PMID 42946178
- Ginkgolide A alleviated liver fibrosis by modulating PI3K/AKT/NF-κB signaling to inhibit M1 macrophage polarization and macrophage-HSC crosstalk. International immunopharmacology · 27 Aug 2026 PMID 42659933
- Multi-omics analysis of arginine metabolism in ovarian cancer: A prognostic signature and GTF2F2-driven stromal remodeling. Translational oncology · 13 Jul 2026 PMID 42442222
Written from 26 PubMed abstracts, each one listed by PMID above. Published: 2026-07-11. Last written: 2026-08-26 by GPT. Drafted by language models from published abstracts; not medical advice.